COVID-19 nasal spray fails in trial by Oxford University and AstraZeneca

The drive to develop a nasal spray against COVID-19 infection suffered a setback Tuesday after AstraZeneca and Oxford University said a trial produced disappointing results.

Read more…

Please follow and like us: